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541 Inﬂuence of Vegetation Size on the Clinical Presentation and Outcome of
Lead-Associated Endocarditis: Results From the MEDIC Registry
Arnold J. Greenspon, Katherine Y. Le, Jordan M. Prutkin, M. Rizwan Sohail,
Holenarasipur R. Vikram, Larry M. Baddour, Stephan B. Danik, James Peacock,
Carlos Falces, Jose M. Miro, Christoph Naber, Roger G. Carrillo, Chi-Hong Tseng,
Daniel Z. Uslan
Vini: Data shows that the rate of cardiac implantable electronic device infection has increased
out of proportion to the increase in device implantations, which is likely a result of increasingly
complex patients undergoing these procedures. In such patients, lead-associated endocarditis
carries a very poor prognosis and clinical predictors that may help with early diagnosis and
treatment are important to identify.
Vidi: In this observational study of 129 patients with lead-associated endocarditis from an
international registry, the authors report that vegetation size (<1 cm vs. 1 cm) was associated
with severity of clinical presentation (local pocket infection vs. systemic infection, respectively)
as well as the microbiological organism (Staphylococcus aureus vs. coagulase-negative
staphylococci).
Vici: This study suggests that vegetation size may be a marker for predicting risk and clinical
outcomes in patients with lead-associated endocarditis. Additional studies would be needed to
investigate whether the use of such a strategy coupled with treatment decisions based on
vegetation size can eventually impact patient and hospital outcomes.
550 EDITORIAL COMMENT A Foregone Conclusion? Risk Stratiﬁcation in
Pacemaker-Associated Endocarditis
Thomas H. Marwick, Prashanthan Sanders
553 Prognostic Value of Echocardiography in Normotensive Patients With
Acute Pulmonary Embolism
Piotr Pruszczyk, Sylwia Goliszek, Barbara Lichodziejewska, Maciej Kostrubiec,
Micha1 Ciurzynski, Katarzyna Kurnicka, Olga Dzikowska-Diduch, Piotr Palczewski,
Anna Wyzgal
Vini: Right ventricular dysfunction (RVD) in pulmonary embolism is most commonly diagnosed
as right ventricular to left ventricular end diastolic ratio (RV/LV) > 0.9. However, there is no
generally accepted consensus on the best echocardiographic deﬁnition of RVD for prognosis in
acute pulmonary embolism (APE).
Vidi: In 411 stable, normotensive patients with APE, TAPSE (<15 mm ¼ increased risk;
>20 mm ¼ very low risk) emerged as the preferable parameter over RV/LV ratio for 30-day APE-
related mortality.
Vici: Measurement of TAPSE may help in the clinical management of stable APE patients.
However, these conclusions from a large observation study will need additional validation.(continued on page A-8)
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A-8561 LGE and NT-proBNP Identify Low Risk of Death or Arrhythmic Events in Patients With
Primary Prevention ICDs
Ify Mordi, Pardeep S. Jhund, Roy S. Gardner, John Payne, David Carrick, Colin Berry,
Nikolaos Tzemos
Vini: Current risk stratiﬁcation tools for implantable cardiac deﬁbrillators (ICDs), which are based
on New York Heart Association functional class and left ventricular ejection fraction (LVEF),
continue to lead to implantation of many devices that may never be used.
Vidi: Using late gadolinium enhancement on cardiac magnetic resonance (CMR) to detect
cardiac ﬁbrosis and N-terminal pro-B type natriuretic peptide (NT–pro-BNP) to improve prog-
nostication, this study was able to identify a low-risk group for death or ICD activation within 157
patients with heart failure of ischemic or nonischemic etiology.
Vici: Traditionally, LVEF has long served as the clinical marker for determining appropriateness
for device therapy in heart failure. This study demonstrates that the torch may have been passed
onto the next generation of imaging modalities. Demonstrating the proof-of-principle, this study
shows that CMR, combined with novel biomarkers, such as NT–pro-BNP, will likely be the future
of cardiac risk assessment.
570 Association of CMR-Measured LA Function With Heart Failure Development:
Results From the MESA Study
Mohammadali Habibi, Harjit Chahal, Anders Opdahl, Ola Gjesdal,
Thomas M. Helle-Valle, Susan R. Heckbert, Robyn McClelland, Colin Wu,
Steven Shea, Gregory Hundley, David A. Bluemke, João A. C. Lima
Vini: It remains unclear whether alterations of left atrial (LA) structure and function precede or
follow the development of heart failure. Novel imaging modalities, such as feature-tracking
magnetic resonance imaging with volume and longitudinal strain measurements, can be used to
answer this question.
Vidi: This case-control nested study from the Multi-Ethnic Study of Atherosclerosis (MESA)
compared LA volume and function in 112 HF cases and 224 control cases in subjects who were
free of any clinical cardiovascular disease at baseline. In multivariate analysis, higher minimal left
atrial volume index and lower peak left atrial longitudinal strain were independently associated
with incident heart failure on follow up.
Vici: Evolving imaging technology allows for improved characterization of LA size and function.
This study suggests that LA dysfunction might be an early marker of developing heart disease
and serve as a weathervane to predict left ventricular dysfunction.(continued on page A-9)
june 2014
volume 7, no. 6
A-9580 Prognostic Value of Coronary CTA in Coronary Bypass Patients:
A Long-Term Follow-Up Study
Saima Mushtaq, Daniele Andreini, Gianluca Pontone, Erika Bertella,
Antonio L. Bartorelli, Edoardo Conte, Andrea Baggiano, Andrea Annoni,
Alberto Formenti, Daniela Trabattoni, Fabrizio Veglia, Francesco Alamanni,
Cesare Fiorentini, Mauro Pepi
Vini: Coronary computed tomography angiography (CTA) has emerged as a valuable diagnostic
and prognostic modality and is gaining widespread popularity. Yet, its role in patients with
atherosclerosis who have previously undergone surgical revascularization with coronary artery
bypass grafts needs to be deﬁned and validated in a large cohort.
Vidi: This large study establishes the number of unprotected coronary territory (UCTs) as
observed by coronary CTA as the strongest multivariable predictors of cardiovascular death
or myocardial infarction (hazard ratio: 7.78 and 10.18 for UCTs 2 and 3, respectively) over
73.5  14.0 months of follow-up.
Vici: The number of UCTs strongly predicts risk of cardiovascular death or myocardial infarction,
and suggests that this information may be helpful for clinical decision-making for post-coronary
artery bypass graft patients. Although this association needs validation in a larger cohort, this
work opens the door for the diagnostic and prognostic use of coronary CTA in patients after
surgical revascularization.
590 EDITORIAL COMMENT Protected Coronary Arteries: Do Open Grafts Pave the
Way to Survival?
Márcio Sommer Bittencourt, Edward HultenS T A T E - O F - T H E - A R T P A P E R S593 Comparative Deﬁnitions for Moderate-Severe Ischemia in Stress Nuclear,
Echocardiography, and Magnetic Resonance Imaging
Leslee J. Shaw, Daniel S. Berman, Michael H. Picard, Matthias G. Friedrich,
Raymond Y. Kwong, Gregg W. Stone, Roxy Senior, James K. Min, Rory Hachamovitch,
Marielle Scherrer-Crosbie, Jennifer H. Mieres, Thomas H. Marwick,
Lawrence M. Phillips, Farooq A. Chaudhry, Patricia A. Pellikka, Piotr Slomka,
Andrew E. Arai, Ami E. Iskandrian, Timothy M. Bateman, Gary V. Heller,
Todd D. Miller, Eike Nagel, Abhinav Goyal, Salvador Borges-Neto, William E. Boden,
Harmony R. Reynolds, Judith S. Hochman, David J. Maron, Pamela S. Douglas,
for the National Institutes of Health/National Heart, Lung,
and Blood Institute–Sponsored ISCHEMIA Trial Investigators
605 Multimodality Imaging of AortitisGregory R. Hartlage, John Palios, Bruce J. Barron, Arthur E. Stillman,
Eduardo Bossone, Stephen D. Clements, Stamatios Lerakis(continued on page A-10)
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A-10C O N C E P T S O N T H E V E R G E O F T R A N S L A T I O N620 Clinical Pacing Post-Conditioning During Revascularization After AMIJohannes Waltenberger, Marloes Gelissen, Sebastiaan C. Bekkers, Jindra Vainer,
Vincent van Ommen, Filip Eerens, Alexander Ruiters, Alexa Holthuijsen, Paqui Cuesta,
Racho Strauven, Eric Mokelke, Anton Gorgels, Frits W. PrinzenI M A G I N G V I G N E T T E627 Emerging Role of MDCT in Planning Complex Structural Transcatheter InterventionJohn A. Newland, Peace Tamuno, Sanjeevan Pasupati, Mark Davis, Adam El-Gamel,
Gerard Devlin, Rajesh K. NairL E T T E R S T O T H E E D I T O R632 Is Low CACs Really Different From Zero.: A Report From the CACTI StudyAmy C. Alman, John E. Hokanson, Gregory L. Kinney, David M. Maahs,
Marian J. Rewers, Janet K. Snell-Bergeon
633 Mechanism of Aortic Valve Opening: Beyond the Pressure GradientKonstantinos C. Siontis, Vuyisile T. Nkomo, Cristina Pislaru, Maurice Enriquez-Sarano,
Patricia A. Pellikka, Sorin V. Pislaru
635 Assessment of Lung Ultrasound Artifacts (B-Lines): Incremental Contribution
to Echocardiography in Heart Failure?
Guglielmo M. Trovato, Daniela Catalano, Marco Sperandeo
635 B-Lines: To Count or Not to Count?Alessandro Zanforlin, Andrea Smargiassi, Riccardo Inchingolo, Sara Sher,
Emilio Ramazzina, Giuseppe Maria Corbo, Gino Soldati
REPLYMarcelo Haertel Miglioranza, Eugenio Picano, Luna Gargani(continued on page A-11)
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A-11E D I T O R ’ S P A G E637 The Last CoverY. Chandrashekhar, Jagat NarulaI M A G I N G C O U N C I L C H A I R M A N ’ S P A G E639 Learning From Our European Imaging ColleaguesNeil J. Weissman, Patrizio LancellottiO N T H E C O V E RPlanning of Complex Structural Transcatheter InterventionsA 76-year-old male developed a perioperative ST-segment elevation myocardial
infarction (STEMI) with pulmonary edema after elective spinal surgery. Emergency
transthoracic echocardiography conﬁrmed post-infarct ventricular septal defect
(VSD). After initial treatment with intra-aortic balloon pump and inotropes,
hemodynamic parameters deteriorated and the option of transcatheter treatment
was explored. Multiplanar multidetector computed tomography (MDCT)
reconstruction conﬁrmed a posterior muscular VSD measuring 16  18 mm (red
stars, top: left and middle panels) and a 3-dimensional (3D) reconstruction of the
VSD in short axis (arrow). Percutaneous closure of the VSD using a 22 mm Amplatzer
VSD Occluder device under real-time 3D transesophageal echocardiography (TEE)
guidance was performed. Hemodynamic parameters improved immediately and
balloon pump was successfully removed. The patient was discharged 5 days later.
Post-procedure TEE shows the VSD device in situ (arrow, bottom left panel) with mild
residual left to right shunt (middle). 3D MDCT shows optimal alignment of the VSD
device (arrow). Please see Newland et al. (page 627) for the related article.
